MARY MOORE: Open Payments
NPI 1477806909 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,770 in 76 payments from 13 companies in 2025. Trend: 2023 $1,227 · 2024 $986 · 2025 $1,770
Food & beverage: $1,678Education: $92
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $305 |
| ABBVIE INC. | 21 | $288 |
| Janssen Biotech, Inc. | 6 | $245 |
| Galderma Laboratories, L.P. | 7 | $228 |
| Regeneron Healthcare Solutions, Inc. | 10 | $160 |
| GENZYME CORPORATION | 5 | $156 |
| Mallinckrodt Hospital Products Inc. | 4 | $94 |
| Organon LLC | 5 | $84 |
| UCB, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, RINVOQ, ILUMYA, SKYRIZI, ACTHAR, Winlevi.
Industry payments across MS — which companies pay providers there.
